Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.110
-0.060 (-5.13%)
At close: Mar 5, 2026, 4:00 PM EST
1.120
+0.010 (0.90%)
After-hours: Mar 5, 2026, 4:19 PM EST
Immunic Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Immunic stock have an average target of 4.25, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 282.88% from the current stock price of 1.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunic stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $5 | Strong Buy | Maintains | $8 → $5 | +350.45% | Mar 2, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +260.36% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +620.72% | Feb 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +620.72% | Jan 7, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +620.72% | Nov 14, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
45.32M
EPS This Year
-0.30
from -0.62
EPS Next Year
-0.37
from -0.30
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 94.8M | |||
| Avg | n/a | 45.3M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.05 | -0.09 | |||
| Avg | -0.30 | -0.37 | |||
| Low | -0.66 | -0.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.